The effect of desulfation of chondroitin sulfate on interactions with positively charged growth factors and upregulation of cartilaginous markers in encapsulated MSCs

Biomaterials

Volumn 34, Issue 21, 2013, Pages 5007-5018

  Lim, Jeremy J ^a   Temenoff, Johnna S ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Cartilage tissue engineering; Chondroitin sulfate; Glycosaminoglycan; Growth factors; Mesenchymal stem cell

Indexed keywords

CARTILAGE TISSUE ENGINEERING; CHONDROITIN SULFATES; GLYCOSAMINOGLYCANS; GROWTH FACTOR; MESENCHYMAL STEM CELL;

CELL CULTURE; COLLAGEN; FLOWCHARTING; GENE EXPRESSION; GLYCOPROTEINS; REPAIR; STEM CELLS; TISSUE; TISSUE ENGINEERING;

HYDROGELS;

AGGRECAN; CHONDROITIN SULFATE; COLLAGEN TYPE 2; GROWTH FACTOR; HISTONE; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL DIFFERENTIATION; CELL ENCAPSULATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HYDROGEL; IN VITRO STUDY; MESENCHYMAL STEM CELL; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEIN SECRETION; SULFATION; UPREGULATION;

ACIDS; BIOLOGICAL MARKERS; CARTILAGE; CELL SURVIVAL; CELLS, IMMOBILIZED; CHONDROCYTES; CHONDROITIN SULFATES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-LINKING REAGENTS; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HISTONES; HUMANS; HYDROGELS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STROMAL CELLS; METHACRYLATES; METHANOL; SULFATES; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 84877025513     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.03.037     Document Type: Article

References (45)

1. Lamberg S.I., Stoolmiller A.C. Glycosaminoglycans. A biochemical and clinical review. JInvest Dermatol 1974, 63:433-449.
2. Lindahl U., Hook M. Glycosaminoglycans and their binding to biological macromolecules. Annu Rev Biochem 1978, 47:385-417.
3. Zafiropoulos A., Fthenou E., Chatzinikolaou G., Tzanakakis G.N. Glycosaminoglycans and PDGF signaling in mesenchymal cells. Connect Tissue Res 2008, 49:153-156.
4. Rider C.C. Heparin/heparan sulphate binding in the TGF-beta cytokine superfamily. Biochem Soc Trans 2006, 34:458-460.
5. Lin X.H. Functions of heparan sulfate proteoglycans in cell signaling during development. Development 2004, 131:6009-6021.
6. Bishop J.R., Schuksz M., Esko J.D. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 2007, 446:1030-1037.
7. Pike D.B., Cai S., Pomraning K.R., Firpo M.A., Fisher R.J., Shu X.Z., et al. Heparin-regulated release of growth factors invitro and angiogenic response invivo to implanted hyaluronan hydrogels containing VEGF and bFGF. Biomaterials 2006, 27:5242-5251.
8. Sakiyama-Elbert S.E., Hubbell J.A. Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix. JControl Release 2000, 69:149-158.
9. Edelman E.R., Mathiowitz E., Langer R., Klagsbrun M. Controlled and modulated release of basic fibroblast growth factor. Biomaterials 1991, 12:619-626.
10. DeLise A.M., Fischer L., Tuan R.S. Cellular interactions and signaling in cartilage development. Osteoarthr Cartil 2000, 8:309-334.
11. Shibata S., Fukada K., Imai H., Abe T., Yamashita Y. In situ hybridization and immunohistochemistry of versican, aggrecan and link protein, and histochemistry of hyaluronan in the developing mouse limb bud cartilage. JAnat 2003, 203:425-432.
12. French M.M., Smith S.E., Akanbi K., Sanford T., Hecht J., Farach-Carson M.C., et al. Expression of the heparan sulfate proteoglycan, perlecan, during mouse embryogenesis and perlecan chondrogenic activity invitro. JCell Biol 1999, 145:1103-1115.
13. Deepa S.S., Umehara Y., Higashiyama S., Itoh N., Sugahara K. Specific molecular interactions of oversulfated chondroitin sulfate E with various heparin-binding growth factors. Implications as a physiological binding partner in the brain and other tissues. JBiol Chem 2002, 277:43707-43716.
14. Hintze V., Miron A., Moeller S., Schnabelrauch M., Wiesmann H.P., Worch H., et al. Sulfated hyaluronan and chondroitin sulfate derivatives interact differently with human transforming growth factor-beta1 (TGF-beta1). Acta Biomater 2012, 8:2144-2152.
15. Varghese S., Hwang N.S., Canver A.C., Theprungsirikul P., Lin D.W., Elisseeff J. Chondroitin sulfate based niches for chondrogenic differentiation of mesenchymal stem cells. Matrix Biol 2008, 27:12-21.
16. Nguyen L.H., Kudva A.K., Guckert N.L., Linse K.D., Roy K. Unique biomaterial compositions direct bone marrow stem cells into specific chondrocytic phenotypes corresponding to the various zones of articular cartilage. Biomaterials 2011, 32:1327-1338.
17. Chen W.C., Yao C.L., Chu I.M., Wei Y.H. Compare the effects of chondrogenesis by culture of human mesenchymal stem cells with various type of the chondroitin sulfate C. JBiosci Bioeng 2011, 111:226-231.
18. Steinmetz N.J., Bryant S.J. Chondroitin sulfate and dynamic loading alter chondrogenesis of human MSCs in PEG hydrogels. Biotechnol Bioeng 2012, 109:2671-2682.
19. Schubert M. Chondroitin from chondroitin sulfate. General polysaccharides 1965, vol. V:109-110. Academic Press, New York. R.L. Whistler, J.N. BeMiller, M.L. Wolfrom (Eds.).
20. Farndale R.W., Buttle D.J., Barrett A.J. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986, 883:173-177.
21. Baier Leach J., Bivens K.A., Patrick C.W., Schmidt C.E. Photocrosslinked hyaluronic acid hydrogels: natural, biodegradable tissue engineering scaffolds. Biotechnol Bioeng 2003, 82:578-589.
22. DeLong S.A., Moon J.J., West J.L. Covalently immobilized gradients of bFGF on hydrogel scaffolds for directed cell migration. Biomaterials 2005, 26:3227-3234.
23. Jo S., Shin H., Shung A.K., Fisher J.P., Mikos A.G. Synthesis and characterization of oligo(poly(ethylene glycol) fumarate) macromer. Macromolecules 2001, 34:2839-2844.
24. Brink K.S., Yang P.J., Temenoff J.S. Degradative properties and cytocompatibility of a mixed-mode hydrogel containing oligo[poly(ethylene glycol)fumarate] and poly(ethylene glycol)dithiol. Acta Biomater 2009, 5:570-579.
25. Yamagata T., Saito H., Habuchi O., Suzuki S. Purification and properties of bacterial chondroitinases and chondrosulfatases. JBiol Chem 1968, 243:1523-1535.
26. Ahn S.J., Costa J., Emanuel J.R. PicoGreen quantitation of DNA: effective evaluation of samples pre- or post-PCR. Nucleic Acids Res 1996, 24:2623-2625.
27. Ruijter J.M., Ramakers C., Hoogaars W.M., Karlen Y., Bakker O., van den Hoff M.J., et al. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res 2009, 37:e45.
28. Box G.E.P., Cox D.R. An analysis of transformations. JR Stat Soc Ser B Stat Methodol 1964, 26:211-252.
29. Nagasawa K., Uchiyama H., Wajima N. Chemical sulfation of preparations of chondroitin 4-sulfate and 6-sulfate, and dermatan sulfate. Preparation of chondroitin sulfate E-like materials from chondroitin 4-sulfate. Carbohydr Res 1986, 158:183-190.
30. Nagasawa K., Inoue Y., Tokuyasu T. Improved method for the preparation of chondroitin by solvolytic desulfation of chondroitin sulfates. JBiochem 1979, 86:1323-1329.
31. Navarro D.A., Flores M.L., Stortz C.A. Microwave-assisted desulfation of sulfated polysaccharides. Carbohydr Polym 2007, 69:742-747.
32. Park J.S., Chu J.S., Tsou A.D., Diop R., Tang Z., Wang A., et al. The effect of matrix stiffness on the differentiation of mesenchymal stem cells in response to TGF-beta. Biomaterials 2011, 32:3921-3930.
33. Kasten P., Beyen I., Niemeyer P., Luginbuhl R., Bohner M., Richter W. Porosity and pore size of beta-tricalcium phosphate scaffold can influence protein production and osteogenic differentiation of human mesenchymal stem cells: an invitro and invivo study. Acta Biomater 2008, 4:1904-1915.
34. Canal T., Peppas N.A. Correlation between mesh size and equilibrium degree of swelling of polymeric networks. JBiomed Mater Res A 1989, 23:1183-1193.
35. Temenoff J.S., Athanasiou K.A., LeBaron R.G., Mikos A.G. Effect of poly(ethylene glycol) molecular weight on tensile and swelling properties of oligo(poly(ethylene glycol) fumarate) hydrogels for cartilage tissue engineering. JBiomed Mater Res 2002, 59:429-437.
36. Steck E., Bertram H., Abel R., Chen B.H., Winter A., Richter W. Induction of intervertebral disc-like cells from adult mesenchymal stem cells. Stem Cells 2005, 23:403-411.
37. Ichinose S., Yamagata K., Sekiya I., Muneta T., Tagami M. Detailed examination of cartilage formation and endochondral ossification using human mesenchymal stem cells. Clin Exp Pharmacol Physiol 2005, 32:561-570.
38. Pelttari K., Winter A., Steck E., Goetzke K., Hennig T., Ochs B.G., et al. Premature induction of hypertrophy during invitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum 2006, 54:3254-3266.
39. Qiu Y., Lim J.J., Scott L., Adams R.C., Bui H.T., Temenoff J.S. PEG-based hydrogels with tunable degradation characteristics to control delivery of marrow stromal cells for tendon overuse injuries. Acta Biomater 2011, 7:959-966.
40. Gobin A.S., West J.L. Cell migration through defined, synthetic ECM analogs. FASEB J 2002, 16:751-753.
41. Hardingham T.E., Fosang A.J. Proteoglycans: many forms and many functions. FASEB J 1992, 6:861-870.
42. Villanueva I., Gladem S.K., Kessler J., Bryant S.J. Dynamic loading stimulates chondrocyte biosynthesis when encapsulated in charged hydrogels prepared from poly(ethylene glycol) and chondroitin sulfate. Matrix Biol 2010, 29:51-62.
43. Villanueva I., Bishop N.L., Bryant S.J. Medium osmolarity and pericellular matrix development improves chondrocyte survival when photoencapsulated in poly(ethylene glycol) hydrogels at low densities. Tissue Eng Part A 2009, 15:3037-3048.
44. Knudson C.B., Knudson W. Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J 1993, 7:1233-1241.
45. Bourguignon L.Y., Singleton P.A., Zhu H., Zhou B. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells. JBiol Chem 2002, 277:39703-39712.